CMPX vs CPB · $367.4M cap vs P/E 12, rev $10.25B
Compass Therapeutics Inc. (CMPX) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
CMPX currently screens at market cap $367.4M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the CMPX and CPB stock pages for the full models.
Not investment advice.